Menu Search
Equities

Abivax SA

AAVXF:PKL

Abivax SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)11.05
  • Today's Change0.00 / 0.00%
  • Shares traded4.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 23 2024 14:28 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in EURView more

In 2023, Abivax SA increased its cash reserves by 834.85%, or 224.99m. Cash Flow from Financing totalled 335.29m or -- of revenues. In addition the company used 97.13m for operations while cash used for investing totalled 8.10m.
Cash flow per share-3.12
Price/Cash flow per share--
Book value per share2.01
Tangible book value per share1.61
More ▼

Balance sheet in EURView more

Abivax SA appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 251.94m. In fact, 0.41% of the value of Abivax SA shares can be attributed to this cash.
Current ratio3.04
Quick ratio--
Total debt/total equity0.7648
Total debt/total capital0.4334
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.